Authors
Latest:
Community-acquired MRSA pericarditisOnly 2 cases of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) pericarditis have been reported in the English literature. Over the last 15 years, CA-MRSA has emerged as an increasingly common pathogen that is genetically and epidemiologically different from hospital-acquired MRSA (HA-MRSA).
Latest:
Glucose-lowering treatment impacts prognosis in diabetic patients after MI: Post hoc analysis of the DIGAMI 2 trialWe conducted a post hoc analysis of the DIGAMI 2 (Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2) trial to assess the impact of glucose-lowering treatment in 1181 diabetic patients who were discharged from the hospital after experiencing a myocardial infarction (MI).
Latest:
Transcatheter Valve Replacement - Advancements in Minimally Invasive Cardiac SurgeryDr. Stewart discusses advancements in cardiac surgery & transcatheter valve replacement therapy.
Latest:
Late mortality with sirolimus-eluting stents in diseased saphenous vein graftsIn a secondary post-hoc analysis of the Reduction of Restenosis in Saphenous Vein Grafts with Cypher (RRISC) trial, we compared the long-term safety of sirolimus-eluting stents (SES) with bare-metal stents (BMS) in diseased saphenous vein grafts
Latest:
The "iPatient" and the Lost Art of the Physical ExamFantastic story from NPR about how some in medicine feel the art of the physical exam is fading in favor of emerging technologies.
Latest:
NAPNAP 2012: Taking Control of Online Healthcare InformationBryn Vartabedian, MD, offers valuable tips and advice for health care providers who are interested in using social media to engage with and educate their patients.
Latest:
Benefit of aspirin plus moderate-intensity oral anticoagulation compared with aspirin alone after acute coronary syndromesThe role of combination therapy with an oral anticoagulant and aspirin for patients recovering from an acute coronary syndrome is still being debated. The results of our meta-analysis showed that treatment with aspirin plus warfarin at international normalized ratio values between 2 and 3 significantly reduces the risk of major adverse events compared with aspirin alone but also increases the risk of major bleeding. For every 100 patients receiving combination therapy, approximately 3 major adverse events are prevented and 1 major hemorrhage occurs.
Latest:
FoundationOne CDx: A Broad Companion Diagnostic Test for Cancer TumorsVincent Miller, MD, chief medical officer of Foundation Medicine, discusses FoundationOne CDx, an FDA-approved diagnostic that is clinically validated for solid tumors.
Latest:
When to Perform Reconstructive Surgery in Children with Facial Birth DefectsBirth defects can set a family up for a lifetime of challenges, but thanks to some amazing advances in modern cosmetic surgery, there are options available to improve a child's quality of life.
Latest:
HIV/AIDS: Progress in TreatmentIn this podcast, Dr. Church reviews the developments of new treatments for HIV.
Latest:
Left ventricular apical ballooning syndrome: A case report of an unusual syndromeA 65-year-old woman with a history of anxiety disorder, dyslipidemia, and recently diagnosed celiac sprue was transferred to the heart center after presenting to a peripheral community hospital with marked fatigue, progressively worsening dyspnea on exertion, and bilateral lower extremity swelling with associated bilateral arm tingling.
Latest:
The Deceptive Income of PhysiciansPhysicians are among the most well-compensated professionals in the US, right? Well, it depends on how you look at it.
Latest:
Cell Phone-based Telemonitoring Helps Cancer: Patients Adhere to Treatment RegimensWireless technologies like cell phones and radio frequency identification can help improve treatment compliance and quality of life for cancer patients.
Latest:
Monitoring Hospital Care Through HCAHPSThe National Association for Healthcare Quality (NAHQ), the Agency for Healthcare Research and Quality (AHRQ), the Leapfrog Group, the Joint Commission, the Institute for Healthcare Improvement (IHI), and the Centers for Medicare and Medicaid Services (CMS) are just a few of the many national and local payers and regulatory agencies that have developed indicators to monitor quality of care.
